Biafungin acetate clinical trials
Also written Rezafungin Acetate.
How each study uses biafungin acetate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the biafungin acetate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- Rezafungin Acetate
- 2
Studies by the year they started
3 studies that test it; most in 2023 (2)
| Year | Studies |
|---|---|
| 2023 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test biafungin acetate.
- Nov 2026Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment OptionsPhase 2 · Mundipharma Research Limited
Studies
Open first, then newest update. How each study uses biafungin acetate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Rezafungin for Treatment of Pneumocystis Pneumonia in HIV AdultsRecruitingPhase 2Mundipharma Research LimitedNCT05835479Written as Rezafungin Acetate / Co Trimoxazole
- Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment OptionsActive, not recruitingPhase 2Mundipharma Research LimitedNCT06794554Written as Rezafungin Acetate
- Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of AgeTerminatedPhase 1Mundipharma Research LimitedNCT05534529Written as Rezafungin Acetate
Codes
What other systems call biafungin acetate · ClinicalTrials.gg INT018289
- UNII (FDA) W1U1TMN677REZAFUNGIN ACETATEConfirmed FDA, Wikidata
- Wikidata Q27292200biafungin acetateConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | W1U1TMN677 | REZAFUNGIN ACETATE | Confirmed FDA, Wikidata |
| Wikidata | Q27292200 | biafungin acetate | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.